PLEASE NOTE: IPWatchdog, Inc. is committed to protecting and respecting your privacy.  By clicking the Register Now button, you consent to allow IPWatchdog, Inc. to store and process the personal information submitted above to provide you the content requested. You can unsubscribe from these communications at any time.  You also consent to allowing IPWatchdog to share your information with the sponsor of this webinar.  

Copyright © 2021

Crystalline/Solid Form Patents in the Life Sciences: Issues in Prosecution and Litigation

In December of 2020, IPWatchdog hosted a webinar discussing the use of and interest in solid-form patents in the pharmaceutical industry. There were many questions during the webinar, and many follow-up inquiries on the “nuts and bolts” of these patents. Issues including prosecution, claim drafting, novelty, obviousness, enablement, non-species claims in a crystalline-form context, claim interpretation and proving infringement.

Join us on Tuesday, May 18, 2021 at 12 PM, for this follow-on webinar that will dive deeper into these questions from a US-based perspective, and which will also compare and contrast these issues with elements of EU law. Panelists will discuss both court decisions as well as opinions from the USPTO (PTAB) and the EPO.

Moderated by Gene Quinn, patent attorney and founder of, with expert commentary and analysis from Eyal Barash, IP Counsel and founder of Barash Law, LLC.

Register Today!

Tuesday, May 18, 2021 at 12 PM Eastern

Sponsored by

Barash Law helps clients build intellectual property to solve business needs. To create IP value, it is essential to understand a client’s business and the science and technology drivers behind the business. At Barash Law, we dive into the technical details and business needs to create fit-for-purpose IP strategies for our clients. For example, Barash Law advises clients who are repositioning and developing drugs on how to create and deliver effective IP strategies with one such strategy utilizing solid forms (e.g., polymorphs, salts, and cocrystals) to generate new highly valuable intellectual property. Barash Law also services as corporate IP counsel to many startups in technologies ranging from pharma and advanced manufacturing to defense and AI-machine learning. Eyal is active on the lecture circuit, speaking for many national and international organizations including for the American Association of Pharmaceutical Sciences, the Defense Entrepreneurs Forum, and the annual Drug Repositioning and Repurposing Conference.

Meet Our Speakers

Founder, Barash Law LLC

Eyal Barash founded Barash Law LLC in 2009 to be a “roving” in-house General and IP counsel to early and mid-stage start-ups primarily coming out of the Purdue Research Park in West Lafayette, Indiana. He advises or has advised more than 20 start-up companies from Purdue alone and taken them through multiple stages of development including in-licenses, out-licenses, public offerings, private sales and public exits. In 2018, one of Eyal’s clients, Endocyte, Inc. was sold to Novartis for over $2B. Eyal was chief patent counsel to Endocyte for almost 10 years. Eyal is also a prolific speaker and lecturer, giving presentations primarily in life science IP throughout the globe. He has a particular interest in drug repositioning and repurposing and lectures on this topic frequently. Eyal’s current clients have a global footprint and are in the pharmaceutical, medical device, energy, defense, and agriculture sectors.

Eyal Barash

President, IPWatchdog, Inc.

Gene Quinn is a US Patent Attorney, the founder of and a Top 300 IP Strategist.  Gene writes about patent law, patent and innovation policy, proposed legislation, rulemaking, software patents and more. In 2014, Mr. Quinn was named one of the top 50 most influential people in IP by Managing IP Magazine. In both 2017 and 2018, he was recognized by IAM Magazine as one of the top IP strategists in the world. Regarded as an expert on software patentability and U.S. patent procedure, Mr. Quinn regularly advises attorneys and clients on patent matters, litigation strategy and appeals. 

Gene Quinn

Accurate Information including Business Email, Full Company Name and Job Title is required!